The Cancer Screening Committee

  • deals with questions surrounding population-based cancer screenings
  • independently assesses scientific evidence and observes developments in Switzerland and abroad
  • considers medical indications, epidemiological, economic, legal and ethical aspects, as well as the interests of patients
  • formulates recommendations for cancer screening measures

Composition of the Committee of Experts

Epidemiology, Methodology, StatisticsProf. Dr. Marcel Zwahlen, Institute for Social and Preventive Medicine, University of Bern, Chairman of the Cancer Screening Committee
Prof. Dr. med. Thomas Agoritsas, Divisions of Internal Medicine & Clinical Epidemiology, Geneva University Hospitals
(Clinical Practice and Prevention)
Prof. Dr. med. Stefan Aebi, Chief physician of medical oncology, Lucerne Cantonal Hospital
Dr med. Kevin Selby, Center for Primary Care and Public Health (Unisanté), Lausanne
ScreeningDr. med. Jacques Fracheboud, retired, formerly Erasmus University Medical Center, Rotterdam, The Netherlands
Health EconomicsProf. Dr. Matthias Schwenkglenks, Institute of Pharmaceutical Medicine, University of Basel, Institute of Epidemiology, Biostatistics and Prevention, University of Zurich
EthicsProf. Dr med. Samia Hurst-Majno, Institute for ethics, history and the humanities, University of Geneva
Law and Ethicslic. iur. Michelle Salathé, Medicine Ethics Law, Basel
Patient partnerDavid U. Haerry, Chairman Positive Council, European Patients Academy (EUPATI), Zurich